• 제목/요약/키워드: Direct costs

검색결과 520건 처리시간 0.029초

Direct Costs of Cervical Cancer Management in Morocco

  • Berraho, Mohamed;Najdi, Adil;Mathoulin-Pelissier, Simone;Salamon, Roger;Nejjari, Chakib
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권7호
    • /
    • pp.3159-3163
    • /
    • 2012
  • Background: For cervical cancer the epidemiological profile is poorly known in Morocco and no data is available concerning the direct medical costs. The purpose of this work is to estimate the direct cost of medical management of invasive cervical cancer during the first year after diagnosis in Morocco. Methods: The estimation of direct costs of medical management of invasive cervical cancer during the first year after diagnosis in Morocco is based on the estimation of individual cost in each stage which covers diagnosis, treatment and follow-up during first year. The cost was estimated per patient and whole cycle-set using the costs for each drug and procedure as indicated by the Moroccan National Agency for Health Insurance. Extrapolation of the results to the whole country was used to calculate the total annual cost of cervical cancer treatments in Morocco. Results: Overall approximately 1,978 new cases of cervical cancer occur each year in Morocco. The majority (82.96%) of these cases were diagnosed at a late stage (stageII or more). The cost of one case of cervical cancer depends on stage of diagnosis, the lowest cost is $382 for stageCis followed by the cost of stageIA1 for young women (< 40 years) which is $2,952. The highest cost is for stageIV, which is $7,827. The total cost of cervical cancer care for one year after diagnosis is estimated at $13,589,360. The share allocated to treatment is the most important part of the global care budget with an annual sum of $13,027,609 whereas other cost components are represented as follows: $435,694 for annual follow-up activity and $126,057 for diagnosis and preclinical staging. Conclusion: This study provides health decision-makers with a first estimate of costs and the opportunity to achieve the optimal use of available data to estimate the needs of health facilities in Morocco.

Evaluation of Interruption Costs for Commercial Customers

  • Choi Sang-Bong;Nam Kee-Young;Kim Dae-Kyeong;Jeong Seong-Hwan;Lee Jae-Duck;Rhoo Hee-Suk
    • KIEE International Transactions on Power Engineering
    • /
    • 제5A권1호
    • /
    • pp.56-61
    • /
    • 2005
  • This paper presents an evaluation of the interruption costs for commercial customers in Korea using customer survey methodology. When various research results are examined, the evaluation of direct interruption costs becomes much more simplified. Especially, in the case of commercial customers, it is known that the evaluation of direct interruption costs is more useful. Accordingly, this paper selected the customer survey method to evaluate the interruption costs for commercial customers in Korea considering interruption and customer characteristics.

산업안전보건관리비 계상기준 개선방안 연구 (A Study on Improving the Occupational Safety and Health Management Cost Calculation Standards)

  • 안방율;송태석
    • 한국건축시공학회:학술대회논문집
    • /
    • 한국건축시공학회 2020년도 봄 학술논문 발표대회
    • /
    • pp.169-170
    • /
    • 2020
  • Occupational Safety and Health Management Cost, used to protect workers in Korean construction worksites and to create safe working environments, is a legally managed expense item. As this cost item is grounded on the Occupational Safety and Health Act, it is always implemented. However, because there is a ceiling on its rates, insufficient amounts of Safety Management Costs are often allocated to worksites, with the money not being used to areas essential to worker safety. As such, the current study raises the need to develop a set of standards to enable some items under the Occupational Safety and Health Management Costs-appropriated under the rate of indirect costs-to be appropriated as direct construction costs. As a preliminary step in this effort, the current study will provide basic data that can be used to create construction cost calculation standards for items that can be calculated as direct construction costs.

  • PDF

치과 임플란트 상향식(bottom-up) 원가산정 (Dental implant bottom-up cost analysis)

  • 김민영;최하나;신호성
    • 대한치과보철학회지
    • /
    • 제52권1호
    • /
    • pp.18-26
    • /
    • 2014
  • 연구 목적: 본 연구의 목적은 가장 최근에 수행된 치과의원의 경영 분석 자료를 바탕으로 상향식 방법을 적용하여 임플란트 원가를 산정하는데 있다. 연구 재료 및 방법: 본 연구에서는 진료행위 각각에 소요되는 직간접 비용을 모두 합산하는 상향식 방식으로 산출하였다. 상향식 원가계산의 경우 총원가는 인건비, 재료비, 관리비, 의료사고비용, 투자자본의 기회비용 등으로 구성이 된다. 이를 임플란트 원가 구성요소로 구분하면 인건비, 기공료, 재료비, 감가상각비 등의 직접비용과 관리운영비를 포함하는 간접비용, 치과의원 투자분에 대한 기회비용으로 구성된다. 결과: 상부보철물의 종류에 따라 금속관일 경우 1,449천원, 도재관일 경우 1,583천원, 오버덴쳐의 경우 2,471천원으로 산정되었다. 임플란트 원가는 인건비, 재료비, 관리비, 기타비용으로 나누어지는데 총 원가 중 인건비가 차지하는 비율은 50%, 재료비 33%, 관리비 15%, 기타비용2%로 나타났다. 이를 직접비, 간접비, 투자비용으로 구분하면 상부 보철물이 금속관일 경우 각각 원가의 83%, 15%, 2%를 차지한다. 결론: 전체 원가 중 인건비가 73만원(약 50%)으로 가장 많은 비중을 차지한다. 상향식 원가계산 결과 관행수가에 근접하게 나타났는데 금속관의 경우 145만원, 도재관일 경우 158만원 추계되었다.

Quantitative Analysis of Magnitude of Rework by Project Types and Sources of Rework

  • 황본강
    • 한국건설관리학회논문집
    • /
    • 제7권6호
    • /
    • pp.202-211
    • /
    • 2006
  • Rework in the construction industry can adversely affect project cost and schedule performance. Based on direct rework costs recorded on 359 construction projects, this paper presents an assessment of the magnitude of rework by various types of projects and sources of rework. The results from this paper establish that on average 4.5% and 2.5% of actual construction costs were spent on rework for owner and contractor projects, respectively. Furthermore, this paper determines that the direct rework costs differ by project types and sources of rework. Finally, it permits the development of rework reduction initiatives. By quantifying and recognizing the different magnitude of rework, the industry can be aware of the waste from rework and develop effective plans for managing rework, ultimately improving project cost performance.

아동 빈곤의 사회경제적 비용 추계 (Estimating the Socioeconomic Costs of Child Poverty)

  • 김수정;정익중
    • 한국사회복지학
    • /
    • 제69권3호
    • /
    • pp.9-33
    • /
    • 2017
  • 본 연구의 목적은 우리나라 아동빈곤의 사회경제적 비용을 추계하는 것이다. 선행 연구를 통해 직접비용과 간접비용 항목을 선정하였고, 선정된 각 비용 항목에 대해 기존 데이터 수집과 전문가 델파이 조사를 진행하여 사회경제적 비용을 산출하였으며, 이러한 총 비용을 우리나라의 GDP에 대비하여 살펴보았다. 본 연구 결과는 다음과 같다. 첫째, 2015년 우리나라 아동빈곤의 사회경제적 비용은 절대 빈곤율 기준 총 55조3,009억(GDP대비 3.5%),상대 빈곤율 기준 99조6,858억원(GDP대비 6.5%)에 이르는 것으로 나타났다. 둘째, 아동 빈곤의 사회경제적 비용은 직접비용에 비해 간접비용이 훨씬 큰 것으로 나타났다. 셋째, 전체 비용 항목 중에서 절대 빈곤율과 상대 빈곤율 기준 모두 가장 큰 비중을 차지하는 것은 생산성 손실과 미취업/실직 등의 고용 관련 비용이었고, 그 다음에 범죄비용으로 나타났다. 이러한 결과를 바탕으로 빈곤 아동에 대한 조기 개입, 부모와 자녀에게 동시에 개입하는 이세대 프로그램 실시, 빈곤 아동 같은 고위험 집단의 경우 장기적이고 지속적인 개입과 더불어 통합적 개입이 필요함을 강조하였다.

  • PDF

아동학대의 사회경제적 비용 추계 (Estimating the Socioeconomic Costs of Child Abuse)

  • 김수정;정익중
    • 한국아동복지학
    • /
    • 제53호
    • /
    • pp.25-50
    • /
    • 2016
  • 본 연구는 우리나라 아동학대의 사회경제적 비용을 추계하는 것이다. 문헌 고찰을 통해 직접비용과 간접비용 항목을 선정하였고, 선정된 각 비용 항목에 대해 기존 데이터 수집과 전문가 델파이 조사를 진행하여 사회경제적 비용을 산출하였으며, 이러한 총 비용을 우리나라의 GDP에 대비하여 살펴보았다. 본 연구 결과는 다음과 같다. 첫째, 2014년 우리나라 아동학대의 사회경제적 비용은 최소 총 3,899억원(GDP 대비 0.03%), 최대 76조원(GDP 대비 5.1%)에 이르는 것으로 나타났다. 둘째, 아동학대의 사회경제적 비용은 직접비용에 비해 간접비용이 훨씬 큰 것으로 나타났다. 셋째, 전체 비용 항목 중에서 가장 큰 비중을 차지하는 것은 고용 관련 비용이었다. 그리고 선진국에 비해 아동보호 직접 예산의 비중이 매우 낮은 것으로 나타났다. 이러한 결과를 바탕으로 아동보호 예산을 늘려야 하고, 아동학대 발견율을 높이는 방안 마련이 시급히 필요하며, 간접비용을 줄이기 위해 학대 경험 아동의 전문적인 조기 치료에 힘쓰는 것이 중요함을 논의하였다.

암환자 1인당 연 평균 직접비용 발생에 대한 연구 (The Study on the annual average direct cost incidence per cancer patient)

  • 유인숙
    • 문화기술의 융합
    • /
    • 제5권4호
    • /
    • pp.137-145
    • /
    • 2019
  • 2012년 한국의료패널 조사 참여자 중에서 암으로 응급, 입원, 외래 서비스를 한 번이라도 이용한 적이 있는 사람 308명이 선정 되었다. 암 환자 1인당 연평균 총직접비용은 환자 의료비, 공단부담금, 비급여 비용을 합산하여 분석하였다. 암 환자가 암으로 지출한 1인당 연평균 총 직접비용 분석 결과는 암 환자 1인당 연평균 총직접비용은 약 129,093,792이고, 남성은 158,100,612원, 여성은 110,482,075이다. 건강보험가입자의 경우 암으로 인한 1인당 총직접비용은 평균 183,095,125원이고 의료급여 수급자는 46,241,705원이었다. 가구 소득별로 보면, 가구 소득 1분위에 속한 환자의 경우 1인당 연평균 총직접비용은 112,459,971원이었고, 2분위에 속한 환자는 137,910,890원, 3분위에 속한 환자는 149,556,570원, 4분위 112,730,461원, 5분위는 142,926,331원이였다.

건강보험 상대가치 개정 연구의 성과와 한계 (The Refinement Project of Health Insurance Relative Value Scales: Results and Limits)

  • 강길원;이충섭
    • 보건행정학회지
    • /
    • 제17권3호
    • /
    • pp.1-25
    • /
    • 2007
  • Relative value scales introduced in 2001 remarkably improved health insurance fee schedule, but current relative value scales have many problems. In the beginning the government intended to introduce 'resource based relative value scales(RBRVSs)' like USA, but political adjustment of RBRVS studied in 19.17 weakened the relationship between relative value scale and resource consumption. So unbalance of health insurance fees are existing till now. Also relative value was not divided to physician work and practice expense, and malpractice fee was not divided separately. To correct the unbalance of current relative value scales, the refinement project of health insurance relative value scales started in 2003. The project team divided relative value scales into three components, which are physician work, practice expense, malpractice fee. Physician work was studied by professional organizations like Korean medical association. To develop the practice expense relative value, project team organized clinical practice expert panels(CPEPs) composed of physicians, nurses, and medical technicians. CPEPs constructed direct expense data like labor costs, material costs, equipment costs about each medical procedures. The practice expense relative values of medical procedures were developed by the allocation of the institution level direct & indirect costs according to CPEPs direct costs. Institution level direct & indirect costs were collected in 21 hospitals, 98 medical clinics, 53 dental clinics, 78 oriental clinics, and 46 pharmacies. The malpractice fee relative values were developed through the survey of malpractice related costs of hospitals, clinics, pharmacies. Putting together three components of relative values in one scale, the final relative values were made. The final relative values were calculated under budget neutrality by medical departments, that is, total relative value score of a department was same before and after the revision. but malpractice fee relative value scores were added to total scores of relative values. So total score of a department was increased by the malpractice fee relative value score of that department This project failed in making 'resource based' relative value scales in the true sense of the word, because the total relative value scores of medical departments were fixed. However the project team constructed the objective basis of relative value scale like physician's work, direct practice expense, malpractice fee. So step by step making process of the basis, the fixation of total scores by the departments will be resolved and the resource based relative value scale will be introduced in true sense.

The evaluation of cost-of-illness due to use of cost-of-illness-based chemicals

  • Hong, Jiyeon;Lee, Yongjin;Lee, Geonwoo;Lee, Hanseul;Yang, Jiyeon
    • Environmental Analysis Health and Toxicology
    • /
    • 제30권sup호
    • /
    • pp.6.1-6.4
    • /
    • 2015
  • Objectives This study is conducted to estimate the cost paid by the public suffering from disease possibly caused by chemical and to examine the effect on public health. Methods Cost-benefit analysis is an important factor in analysis and decision-making and is an important policy decision tool in many countries. Cost-of-illness (COI), a kind of scale-based analysis method, estimates the potential value lost as a result of illness as a monetary unit and calculates the cost in terms of direct, indirect and psychological costs. This study estimates direct medical costs, transportation fees for hospitalization and outpatient treatment, and nursing fees through a number of patients suffering from disease caused by chemicals in order to analyze COI, taking into account the cost of productivity loss as an indirect cost. Results The total yearly cost of the diseases studied in 2012 is calculated as 77 million Korean won (KRW) per person. The direct and indirect costs being 52 million KRW and 23 million KRW, respectively. Within the total cost of illness, mental and behavioral disability costs amounted to 16 million KRW, relevant blood immunological parameters costs were 7.4 million KRW, and disease of the nervous system costs were 6.7 million KRW. Conclusions This study reports on a survey conducted by experts regarding diseases possibly caused by chemicals and estimates the cost for the general public. The results can be used to formulate a basic report for a social-economic evaluation of the permitted use of chemicals and limits of usage.